Implanet Receives FDA Clearance and CE Mark for Jazz Claw Implant

Implanet received FDA 510(k) clearance and CE Mark approval for the Jazz Claw®, a hybrid-implant designed to treat degenerative spinal pathologies in adults, including kyphosis.

The Jazz Claw seeks to provide autostable posterior fixation by replacing traditional hook-and-screw fixation systems.

Source: Implanet

The addition...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us